Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03285061|
Recruitment Status : Completed
First Posted : September 15, 2017
Last Update Posted : July 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Medication Disposal Behavior||Device: Deterra Drug Deactivation System||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery|
|Actual Study Start Date :||October 1, 2017|
|Actual Primary Completion Date :||July 1, 2019|
|Actual Study Completion Date :||July 1, 2019|
No Intervention: Standard Disposal Instructions
These patients will receive standard instructions on proper disposal of excess pain medication following orthopedic foot and ankle surgery. They will be asked complete a survey at their 6 post operative follow-up on excess medication disposal.
Experimental: At Home Disposal
With patients' prescription for post operative pain medication, a Deterra portable drug deactivation system will be provided, along with instructions on proper use. They will be asked complete a survey at their 6 post operative follow-up on excess medication disposal.
Device: Deterra Drug Deactivation System
A portable bag that will neutralize and dissolve excess medication, rendering it completely unusable and safe for landfill disposal. The system meets FDA and DEA standards for at home disposal systems.
- Patients' Drug Disposal Methods using a survey [ Time Frame: 6 weeks ]Patients will be given a survey to obtain their method of disposal for excess post-operative pain medication.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03285061
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02130|
|Principal Investigator:||Christopher Chiodo, MD||Brigham and Women's Hospital|